You are using an outdated browser. Please upgrade your browser to improve your experience.

You are here

Rheumatoid Arthritis

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.

ACP supports this measure with modifications.

ID# NQF 0054
ID# PQRS 108

More Information

Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy for Rheumatoid Arthritis

The percentage of patients 18 years and older by the end of the measurement period, diagnosed with rheumatoid arthritis and who had at least one ambulatory prescription for a disease-modifying anti-rheumatic drug.
Date Reviewed: April 27, 2015

ACP supports this measure.

ID# NQF 2522
ID# PQRS 176

More Information

Rheumatoid Arthritis: Tuberculosis Screening

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who have documentation of a tuberculosis (TB) screening performed within 12 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug (DMARD).
Date Reviewed: April 27, 2015

ACP supports this measure.

ID# NQF 2523
ID# PQRS 177

More Information

Rheumatoid Arthritis: Assessment of Disease Activity

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) and >=50% of total number of outpatient RA encounters in the measurement year with assessment of disease activity using a standardized measure.
Date Reviewed: April 27, 2015

ACP supports this measure.

ID# NQF 2524
ID# PQRS 178

More Information

Rheumatoid Arthritis: Functional Status Assessment

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis for whom a functional status assessment was performed at least once during the measurement period.
Date Reviewed: April 27, 2015

ACP supports this measure with modifications.

ID# NQF 0421

More Information

Rheumatoid Arthritis (RA): Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who are newly prescribed disease modifying anti-rheumatic drug therapy within 12 months.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# PQRS 179

More Information

Assessment and Classification of Disease Prognosis

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# PQRS 180

More Information

Glucocorticoid Management

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 months.
Date Reviewed: April 27, 2015